Pyxis Oncology, Inc.·4

Sep 27, 6:37 PM ET

Wadhane Jitendra 4

4 · Pyxis Oncology, Inc. · Filed Sep 27, 2023

Insider Transaction Report

Form 4
Period: 2023-09-27
Wadhane Jitendra
SVP, Chief Accounting Officer
Transactions
  • Purchase

    Common Stock

    2023-09-27$1.87/sh+2,500$4,675226,937 total
Footnotes (1)
  • [F1]The Reporting Person purchased all 2,500 shares of common stock in the open market at a price of $1.87 per share.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION